Prophylactic ICD Survival Benefit Prediction: Review and Comparison between Main Scores.

Area of Science:

• Cardiology
• Medical Devices
• Predictive Analytics

Background:

• Current guidelines recommend prophylactic implantable cardioverter-defibrillators (ICDs) for symptomatic heart failure (HF) patients with low ejection fraction (EF).
• However, many patients do not benefit from ICDs, and some experience device-related complications, necessitating better risk stratification.
• Scoring systems are crucial for identifying subgroups with differential ICD survival benefits to maximize efficacy and minimize harm.

Purpose of the Study:

• To review and evaluate existing scoring systems for predicting survival benefits of prophylactic ICDs in heart failure patients.
• To assess the utility of cardiac MRI (CMR) and genetic analysis in predicting ventricular arrhythmias (VAs).
• To determine if current scores can guide clinical decisions for ICD implantation.

Main Methods:

• Review of established risk scores like the MADIT trial-based Risk Stratification Score (MRSS) and Seattle Heart Failure Model (SHFM).
• Analysis of studies utilizing cardiac MRI (CMR) for predicting ventricular arrhythmias (VAs).
• Examination of data on the predictive value of genetic analysis for arrhythmic risk.

Main Results:

• Most scoring systems primarily predict mortality rather than sustained ventricular arrhythmia (VA) incidence.
• Multiple scores effectively identify high-risk subgroups with high early mortality post-ICD implant.
• Low- and medium-risk subgroups showed actual ICD survival benefit with MRSS and SHFM, while high-risk subgroups (16-20%) showed no benefit.
• CMR reliably identified myocardial scar and 'channels' associated with VA.
• Genetic analysis identified mutations predicting increased arrhythmic risk in a subset of patients.

Conclusions:

• Current scoring models can delineate patient subgroups with varying prophylactic ICD benefits but lack sufficient predictability for guideline implementation.
• These scores can assist in borderline cases, particularly in elderly patients or those with comorbidities.
• Cardiac MRI shows promise in identifying VA risk beyond ejection fraction alone.
• Genetic analysis may further refine risk stratification for arrhythmic events.